|
 |
| Established
1999 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| Source: Company documents |
|
|
| Name
: |
Tom R. DeMeester |
| Title
: |
Chairman of the Board |
| Since: |
03/2000 |
|
|
|
|
| Name
: |
Kathleen Danenberg |
| Title
: |
President, Chief Executive Officer, Director |
| Since: |
12/2000 |
|
|
|
|
| Name
: |
David M. Smith |
| Title
: |
Vice Chairman of the Board |
| Since: |
12/1999 |
|
|
|
|
| Name
: |
Thomas Stankovich |
| Title
: |
Chief Financial Officer, Vice President, Secretary |
| Since: |
11/2006 |
|
|
|
|
| Name
: |
James Clark |
| Title
: |
Chief Operating Officer, Vice President |
| Since: |
10/2006 |
|
|
|
|
|
|
|
| |
|
| Earnings
Release Dates : 12th August 2008 , 15th May 2008 , 26th March 2008 , 14th November 2007 |
|
 Audio |
|
|
| |
|
| |
|
| |
|
| |
| Infinera Soars 63% At Start Jun 11, 4:33 PM EDT |
|
| |
Responce Genetics Inc.
The Company’s products are targeted for potential use in the treatment of cancer.
The Company has developed and patented enabling technologies for maximizing extraction and analysis of nucleic acids and, as a result, for accessing the genetic information in tumor samples that are stored as formalin-fixed and paraffin-embedded, or FFPE specimens.
The Company is researching and developing diagnostic tests for cancer by identifying genetic profiles of tumors that are more aggressive and recur rapidly after surgery.
|
| More... |
|
|
|
|
|
|
|
|
|
|
| ©
1999-2008 123jump.com. All rights reserved |
|
|
|
|
|
|
|
Warning: Unknown: Your script possibly relies on a session side-effect which existed until PHP 4.2.3. Please be advised that the session extension does not consider global variables as a source of data, unless register_globals is enabled. You can disable this functionality and this warning by setting session.bug_compat_42 or session.bug_compat_warn to off, respectively. in Unknown on line 0
|
